PSCRO May 3, 2020 Articles Abstract Abstract unavailable. Please download related documents below. PSCRO.2020.8e1001 (May 1, 2020) Elena Zuber, Diana Schweitzer, Dominick Allen, Seema Parte, and Sham S. Kakar Download Full Text Download Full Article PDF DOI: 14343/PSCRO.2020.8e1001 Tags: Pranela Rameshwar Continue Reading Previous PostChallenges in Leveraging Cancer Stem Cell Properties for Therapeutic Development You Might Also Like Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics February 27, 2015 Stem cell and cancer stem cell games on the ECM field August 5, 2013 The role of osteoclasts in early dissemination of prostate cancer tumor cells June 4, 2015
Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics February 27, 2015